Literature DB >> 18942661

The Queensland Cancer Risk Study: general population norms for the Functional Assessment of Cancer Therapy-General (FACT-G).

Monika Janda1, Tracey DiSipio, Cameron Hurst, David Cella, Beth Newman.   

Abstract

OBJECTIVE: To derive Australian normative scores for the Functional Assessment of Cancer Therapy-General Population (FACT-GP) and to confirm its factor structure.
METHODS: Quality of life (QoL) data (as measured by the FACT-GP) were collected within the Queensland Cancer Risk Study (QCRS) in 2004. The QCRS explored cancer screening and cancer risk behaviours among 9419 English-speaking residents of Queensland aged 20-75 years. Information was collected through computer-assisted telephone interviews and augmented by mailed, Self-Administered Questionnaires (SAQ). A total of 2727 participants largely comparable to the general population of Queensland self-completed the FACT-GP; however, participants were somewhat higher educated, more likely to have had cancer and less likely to be of indigenous heritage.
RESULTS: The Queensland population reported a FACT-GP summary score of 85.9 (SD=15.1), with subscale scores (range: 19.2 for social well-being to 25.1 for physical well-being (PWB)). In this study, men and women within different age groups reported similar QoL. QoL was clinically and significantly lower among participants not married, with a body mass index (BMI) deviating from normal weight and with one or more self-reported morbidities. A four-factor solution was confirmed with good goodness-of-fit indices (RSMEA<0.05 for all three age groups).
CONCLUSIONS: The reference values from the general population reported here can be used for comparison with the QoL measured in populations of cancer patients, providing a benchmark against which clinicians can evaluate the impact of the disease and/or the treatments on QoL.

Entities:  

Mesh:

Year:  2009        PMID: 18942661     DOI: 10.1002/pon.1428

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  16 in total

1.  A supportive care intervention for people with metastatic melanoma being treated with immunotherapy: a pilot study assessing feasibility, perceived benefit, and acceptability.

Authors:  Judith Lacey; Anna J Lomax; Catriona McNeil; Michael Marthick; David Levy; Steven Kao; Theresa Nielsen; Haryana M Dhillon
Journal:  Support Care Cancer       Date:  2018-11-03       Impact factor: 3.603

2.  Determinants of quality of life in patients with advanced cancer.

Authors:  Camilla Zimmermann; Debika Burman; Nadia Swami; Monika K Krzyzanowska; Natasha Leighl; Malcolm Moore; Gary Rodin; Ian Tannock
Journal:  Support Care Cancer       Date:  2010-03-30       Impact factor: 3.603

Review 3.  Systematic review of caregiver responses for patient health-related quality of life in adult cancer care.

Authors:  Jessica K Roydhouse; Ira B Wilson
Journal:  Qual Life Res       Date:  2017-03-14       Impact factor: 4.147

4.  Health concerns of cancer survivors after primary anti-cancer treatment.

Authors:  S Y Tan; J Turner; K Kerin-Ayres; S Butler; C Deguchi; S Khatri; C Mo; A Warby; I Cunningham; A Malalasekera; H M Dhillon; Janette L Vardy
Journal:  Support Care Cancer       Date:  2019-02-01       Impact factor: 3.603

5.  Two-year patient-reported outcomes following treatment of uveal melanoma.

Authors:  L Hope-Stone; S L Brown; H Heimann; B Damato; P Salmon
Journal:  Eye (Lond)       Date:  2016-09-02       Impact factor: 3.775

6.  Perceptions of care and patient-reported outcomes in people living with neuroendocrine tumours.

Authors:  Vanessa L Beesley; Matthew Burge; Monica Dumbrava; Jack Callum; Rachel E Neale; David K Wyld
Journal:  Support Care Cancer       Date:  2018-03-29       Impact factor: 3.603

7.  Symptoms and quality of life of advanced cancer patients at home: a cross-sectional study in Shanghai, China.

Authors:  Yixin Wang; Jie Shen; Yan Xu
Journal:  Support Care Cancer       Date:  2010-04-28       Impact factor: 3.603

8.  Technology and quality of life outcomes.

Authors:  Eileen Danaher Hacker
Journal:  Semin Oncol Nurs       Date:  2010-02       Impact factor: 2.315

Review 9.  Chronic adverse events and quality of life after radiochemotherapy in anal cancer patients. A single institution experience and review of the literature.

Authors:  K Fakhrian; T Sauer; A Dinkel; S Klemm; T Schuster; M Molls; H Geinitz
Journal:  Strahlenther Onkol       Date:  2013-05-02       Impact factor: 3.621

10.  Mechanisms of navigating goals after testicular cancer: meaning and emotion regulation.

Authors:  Michael A Hoyt; Christian J Nelson; Katie Darabos; Amanda Marín-Chollom; Annette L Stanton
Journal:  Psychooncology       Date:  2016-01-13       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.